Menu Menu

NAMSW    Newamsterdam Pharma Co Nv    1936258    
Income Statement
Revenue nams-20241231 45,563,000
Net Income nams-20241231 -241,598,000
Profit Margin -530.25%

Balance Sheet
Current Assets 863,413,000
Assets 864,620,000
Current Liabilities 106,918,000
Liabilities 107,120,000
Equity 757,500,000

Cash Flow Statement
Operating Cash Flow -158,564,000
Investing Cash Flow -62,848,000

Market Analysis
Price 13.00
BVPS 295.36
PB 0.04
PS 0.01
FCF -221,412,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
2/26 -2.56
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Find a discrepancy? The most accurate way to find company fundamental data is to view NAMSW documents filed with the SEC.


NAMSW Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker:



View A List of Tickers





We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas